Cell-free biomanufacturing platform for sustainable chemical production.
| Date | Round | Amount |
|---|---|---|
| Dec 2022 | Series B Stockholm-based biomanufacturing company EnginZyme raised a EUR21M Series B from new backers Almi Invest GreenTech, Navigare Ventures and Bunge Ventures, with Sofinnova Partners, Industrifonden and SEB GreenTech VC returning. | $22.7M |